Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Capozzi

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
The Journal of Infectious Diseases|March 9, 1999
Enhanced production of tumor necrosis factor-alpha and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1A Bergamini, E Faggioli, F Bolacchi, et al.
Clinical and Experimental Immunology|April 12, 2001
Lack of evidence for the Th2 predominance in patients with chronic hepatitis CA Bergamini, F Bolacchi, G Cerasari, et al.
Journal of Medicinal Chemistry|July 21, 2001
Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agentG Campiani, F Aiello, M Fabbrini, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
The Journal of Infectious Diseases|March 9, 1999
Enhanced production of tumor necrosis factor-alpha and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1A Bergamini, E Faggioli, F Bolacchi, et al.
Clinical and Experimental Immunology|April 12, 2001
Lack of evidence for the Th2 predominance in patients with chronic hepatitis CA Bergamini, F Bolacchi, G Cerasari, et al.
Journal of Medicinal Chemistry|July 21, 2001
Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agentG Campiani, F Aiello, M Fabbrini, et al.
Pageof 6